Scolopamine Transdermal System has 6 known drug interactions based on U.S. FDA drug labeling data. 6 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Alcohol, Belladonna Alkaloids, Meclizine. Patients taking Scolopamine Transdermal System should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 6
- Major
- 6
Major (6)
- Scolopamine Transdermal System + Alcohol— Concurrent use may potentiate CNS adverse reactions including drowsiness, dizziness, and disorientation.
- Scolopamine Transdermal System + Belladonna Alkaloids— Concurrent use may potentiate CNS adverse reactions and increase risk of anticholinergic effects, intestinal obstruction…
- Scolopamine Transdermal System + Meclizine— Concurrent use may potentiate CNS adverse reactions including drowsiness, dizziness, and disorientation.
- Scolopamine Transdermal System + Muscle Relaxants— Concurrent use may potentiate CNS adverse reactions including drowsiness, dizziness, and disorientation.
- Scolopamine Transdermal System + Sedating Antihistamines— Concurrent use may potentiate CNS adverse reactions including drowsiness, dizziness, and disorientation.
- Scolopamine Transdermal System + Sedatives— Concurrent use may potentiate CNS adverse reactions including drowsiness, dizziness, and disorientation.